Aquinox Pharmaceuticals Forecast and Stock Analysis
Technical AQXP stock analysis for April 25, 2019.
Aquinox Pharmaceuticals fell by -0.37% in the last day from $2.73 to $2.72 The price has been going up and down for this period, and there has been a 3.03% gain for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -50 577 shares and in total 89 543 shares bought and sold for approximately $243 557.00.
Close price at the end of the last trading day (Thursday, 25th Apr 2019) of the AQXP stock was $2.72. This is 0.37% less than the trading day before Wednesday, 24th Apr 2019.
During day the stock fluctuated 4.55% from a day low at $2.64 to a day high of $2.76.
30 day high of the AQXP stock price was $2.79 and low was $2.54.
90 day high was $2.89 and low was $2.18.
52 week high for the Aquinox Pharmaceuticals - $16.14 and low - $1.96.
Aquinox Pharmaceuticals lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.85% during the next 3 months and, with 90% probability hold a price between $2.79 and $3.28 at the end of this period.
Aquinox Pharmaceuticals holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $2.65 and $2.67. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday April 24, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 55 and the stock is currently not being overbought or oversold
Support & Resistance
Aquinox Pharmaceuticals finds support from accumulated volume at $2.67.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
Aquinox Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|AQXP $2.72 ($-0.01 -0.37%)|
AQXP is down $0.01 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AQXP based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AQXP analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us